Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Stanford Group Upgrades Human Genome (HGSI) to Buy
-
Stanford Downgrades First Solar (FSLR) to Sell
-
Stanford Upgrades Leap Wireless (LEAP) to Buy
-
Stanford Upgrades Ultra Petroleum (UPL) to Buy
-
Stanford Downgrades Aqua America (WTR) to Hold
-
Stanford Starts Energy Recovery (ERII) at Buy
-
Stanford Upgrades Fluor (FLR) to Buy
-
Stanford Starts Kindred Healthcare (KND) at Buy
-
Stanford Starts Amazon.com (AMZN) at Sell
-
Stanford Downgrades Digimarc (DMRC) to Hold
-
Stanford Upgrades AeroVironment (AVAV) to Buy
-
Stanford Group Initiates Coverage on IAC/InteractiveCorp (IACI)
-
Stanford Starts Cubic (CUB) at Buy
-
Anadarko Petroleum (APC) volatility stays Elevated after EPS
-
Stanford Group Downgrades Analogic (ALOG) to Hold
-
Stanford Upgrades LaserCard (LCRD) to Buy
-
Stanford Upgrades Apache (APA) to Buy
-
Notable Analyst Rating Changes 10/24: RTN, BG, HD, DO Upgraded; NOV, LVLT, AFFX, ZMH Downgraded
-
Stanford Downgrades Zimmer Holdings (ZMH) to Hold
-
Stanford Starts AuthenTec (AUTH) at Buy
-
Stanford Upgrades Ormat Technologies (ORA) to Buy
-
Stanford Downgrades Entercom (ETM) to Sell
-
Stanford Downgrades Cumulus Media (CMLS) to Sell
-
Stanford Upgrades Virgin Mobile USA (VM) to Hold
-
Stanford Upgrades Apria (AHG) to Buy
-
Notable Analyst Rating Changes 10/9: HRC, PTV, ORCL Upgraded; X, AKS, GOOG, CBS Downgraded
-
Stanford Starts Bidz.com (BIDZ) at Hold
-
Stanford Starts American Superconductor (AMSC) at Hold
-
Stanford Starts Seattle Genetics (SGEN) at Hold
-
Stanford Starts Incyte (INCY) at Buy
-
Stanford Starts Par Pharmaceutical (PRX) at Hold
-
Stanford Starts Medicis Pharma (MRX) at Hold
-
Stanford Starts Javelin Pharmaceuticals (JAV) at Buy
-
Stanford Starts Mylan (MYL) at Buy
-
Stanford Starts Cephalon (CEPH) at Buy
-
Stanford Starts Endo Pharmacuticals (ENDP) at Buy
-
Stanford Starts K-V Pharmaceutical (KVA) at Hold
-
Stanford Starts Forest Labs (FRX) at Sell
-
Stanford Starts Obagi Medical (OMPI) at Buy
-
Stanford Starts Teva Pharmaceuticals (TEVA) at Buy
-
Stanford Upgrades Ceradyne (CRDN) to Buy
-
Energy Conversion (ENER) volatility Elevated at 100 into Senate passage of renewable energy bill
-
Notable Analyst Rating Changes 9/23: NLY, SSCC, APC Upgraded; GE, FIG, CC, MPEL Downgraded
-
Stanford Upgrades Anadarko Petroleum (APC) to Buy
-
Stanford Starts Medical Equipment & Supplies Stocks (SYK, MNT, ZMH, BEAT, more..)
-
Notable Analyst Rating Changes 9/18: HOC, PTR, CLR, NOV Upgraded; TGT, NT, KSS, CLI Downgraded
-
Stanford Upgrades National Oilwell Varco (NOV) to Buy
-
Stanford Upgrades Cameron Int'l (CAM) to Buy
-
Stanford Starts Western Gas Partners (WES) at Buy
-
Stanford Starts Pioneer Southwest Energy (PSE) at Buy


